Embattled drugmaker Indivior raises forecasts on Suboxone strength

by on June 17, 2020

Indivior Plc on Tuesday raised its full-year forecasts as the embattled British drugmaker’s best-selling opioid addiction drug Suboxone fared better than expected in the face of competition from copycats. (Source: Reuters: Health)

Previous post:

Next post: